Latest1 information on COVID-19
©2022 Stanford Medicine
Recruiting
I'm InterestedTrial ID: NCT04885127
The Feasibility of Telehealth-Based Palliative Care Intervention and Digital Symptom Monitoring on Patients With AML Receiving Low-Intensity Induction Therapy
Assistant Professor of Medicine (Hematology)
Clinical Associate Professor, Medicine - Oncology
Inclusion Criteria:
- Patients being treated for a diagnosis of acute myeloid leukemia at Stanford Cancer
Center
- Patients determined to be candidates for low intensity induction therapy (not
requiring hospitalization to administer treatment) by their leukemia physician
- Estimated life expectancy of 6 months
- Functional status at the level of at least being capable of limited self-care,
confined to chair or bed for half the day or better
- Access to smartphone, tablet, or computer with capability to utilize a symptom
tracking application
Exclusion Criteria:
- Relapsed or refractory AML
- Patients who have established care with palliative care previously
- Non-English-speaking, as the Noona application is developed in the English language
other: Palliative Care + Digital Symptom Monitoring
Recruiting
I'm Interested
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Irena Tan, MD